ISRG241220C420000
- 127.03
- 0.000.00%
Intuitive Surgical Newsroom
Mizuho Securities Maintains Intuitive Surgical(ISRG.US) With Hold Rating, Raises Target Price to $570
Bernstein Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $650
Citigroup Maintains Buy on Intuitive Surgical, Raises Price Target to $640
Intuitive Surgical Analyst Ratings
Wells Fargo Maintains Overweight on Intuitive Surgical, Raises Price Target to $630
Citi Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $640
Wells Fargo Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $630
Stifel Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $610
Intuitive Surgical Analyst Ratings
Stifel Adjusts Price Target on Intuitive Surgical to $610 From $525, Keeps Buy Rating
Morgan Stanley Initiates Intuitive Surgical(ISRG.US) With Buy Rating, Announces Target Price $650
Intuitive Surgical (ISRG) Gets a Buy From Leerink Partners
Intuitive Surgical Is Maintained at Buy by BTIG
Intuitive Surgical Analyst Ratings
BTIG Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $561
BTIG Adjusts Price Target on Intuitive Surgical to $561 From $535, Maintains Buy Rating
Intuitive Surgical Analyst Ratings
Erste Group Initiates Intuitive Surgical(ISRG.US) With Buy Rating
HSBC Raises Intuitive Surgical Price Target to $643 From $586
BofA Securities Maintains Intuitive Surgical(ISRG.US) With Buy Rating